Innovative Dengue Vaccine Candidate Found Effective and Safe - Vax-Before-Travel

(Vax Before Travel)

A second dengue prevention vaccine may soon become available around the world. Japan-based Takeda announced that its dengue vaccine candidate, TAK-003, was recently found very effective in a phase 3 clinical study.

TAK-003 prevented 84% of hospitalized dengue cases and 61% of symptomatic dengue cases, with no important safety risks identified, in the overall population, including both seropositive and seronegative individuals through 54 months after vaccination.

"The burden of dengue is far-reaching, and over half of the world's population is at risk of dengue each year," said Eng Eong Ooi, Ph.D., M.D., Duke-NUS Medical School, Singapore, in a press release issue don June 9, 2022. 

"There is an urgent need for impactful prevention tools to combat the disease."

TAK-003 is currently undergoing regulatory review to prevent dengue disease in children and adults in the European Union and select dengue-endemic countries.

The current U.S. FDA-approved dengue vaccine Dengvaxia is available with testing requirements.

Since June 1, 2022, the WHO recommends that dengue vaccines be given to persons with confirmed prior dengue virus infection.

From 2010 to 2020, approximately 95% of locally acquired dengue cases in the USA (n = 31,289) occurred in Puerto Rico.

In 2022, the CDC has confirmed 101 locally acquired dengue cases in Puerto Rico.

Additional dengue vaccine news is posted at Vax-Before-Travel.com/Dengue.

Note: This announcement was manually curated for mobile readers.

-

Comments

Post a Comment

Popular Posts

UKHSA Advisory Board: preparedness for infectious disease threats

Image
pneumo :: Article Creator How Often Do You Need To Get A Pneumonia Shot? The pneumonia shot is a vaccine that helps protect you against pneumococcal disease, or diseases caused by bacteria known as Streptococcus pneumoniae. The vaccine can help protect you from pneumococcal disease for many years. One of the most common causes of pneumonia is infection of the lungs with the bacteria Streptococcus pneumoniae. These bacteria mainly affect your lungs and can cause sometimes life-threatening infections in other parts of your body, too, including the bloodstream (bacteremia), or brain and spine (meningitis). The pneumonia shot is especially recommended if you fall into one of these age groups: Younger than 2 years old: four shots (at 2 months, 4 months, 6 months, and then a booster between 12 and 15 months) 65 years old or older: two shots, which will last you the rest of your life Between 2 and 64 years old: between one and thr
Read more